NDC 71837-5843 – Leukine
Sargramostim 250 ug/mL · Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous
Product NDC71837-5843
Product details
- Brand name
- Leukine
- Generic name
- Sargramostim
- Labeler
- Partner Therapeutics, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous, Subcutaneous
- Marketing category
- BLA · BLA103362
- Marketed since
- September 1, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Leukocyte Growth Factor
Active ingredients
- Sargramostim 250 ug/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71837-5843-5 | 5 VIAL, SINGLE-DOSE in 1 CARTON (71837-5843-5) / 1 mL in 1 VIAL, SINGLE-DOSE (71837-5843-1) | Sep 1, 2023 |
Recalls mentioning this NDC
- D-0655-2021 Jul 21, 2021 · Class III
FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.